. Author manuscript; available in PMC: 2013 Aug 14.

Published in final edited form as: Antivir Ther. 2012;17(1):25–33. doi: 10.3851/IMP1915

Table 3.

Predicted optimal dosage regimens of LFV/ritonavir when rifampicin is coadministered based on simulations using the final combined model

	LPV:ritonavir =4:1		LPV:ritonavir =1:1 12-hourly LPV dose, mg/kg
Body weight, kg	12-hourly LPV dose, mg/kg	8-hourly LPV dose, mg/kg	LPV:ritonavir =1:1 12-hourly LPV dose, mg/kg
3.0–5.9	52	27	22
6.0–9.9	40	21	16
10.0–13.9	35	20	14
14.0–19.9	30	18	12

LPV, lopinavir.